Stay updated on Pyrotinib + Trastuzumab in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib + Trastuzumab in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib + Trastuzumab in HER2+ Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision v3.4.3 was added to the Record History. Revision v3.4.2 was removed.
    Difference
    0.2%
    Check dated 2026-03-10T15:34:51.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A new revision entry v3.4.2 was added to the history and the previous revision v3.4.1 was removed.
    Difference
    0.1%
    Check dated 2026-02-17T04:17:00.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.1) was added to the record history, and older items—including a funding-lapse notice and the v3.4.0 revision—were removed.
    Difference
    0.9%
    Check dated 2026-02-10T01:22:45.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    A government funding lapse notice appears at the top of the page, informing users that information may not be up to date and providing links to cc.nih.gov and opm.gov.
    Difference
    0.8%
    Check dated 2026-02-02T21:51:35.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    UI enhancements include showing the glossary option and color-coded indicators for additions and deletions, along with updated revision notes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1%
    Check dated 2026-01-26T20:43:09.000Z thumbnail image
  8. Check
    54 days ago
    Change Detected
    Summary
    A new revision entry (v3.3.4) was added to the Record History, reflecting a routine update to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-19T15:30:37.000Z thumbnail image

Stay in the know with updates to Pyrotinib + Trastuzumab in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib + Trastuzumab in HER2+ Breast Cancer Clinical Trial page.